Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions

Ivo J P Arnhold, S. B. Oliveira, M. G F Osorio, A. J F Carrilho, W. Nicolau, A. C. Bianco, B. B. Mendonca

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Two patients with growth hormone (GH) gene deletions were treated with recombinant insulin-like growth factor-I (IGF-I) (80-240 (μg/kg/day) and the effects on bone mass and body composition were compared to administration of GH (0.075 U/kg/day) to 8 patients with idiopathic GH deficiency. Bone mass and body composition were measured by dual photon X-ray absorptiometry (DEXA) before and 3 and 6 months after treatment with GH or IGF-I. Similar increases in growth velocities were observed after GH and IGF-I treatment. Treatment with GH resulted in prompt and significant reduction in body fat percentage (basal, 3 and 6 months: 22±10, 17±9, and 16±9%) whereas body fat percentage remained unchanged after IGF-I therapy (basal, 3 and 6 months: 49, 52 and 48% in patient 1 and 45, 42 and 43% in patient 2, respectively). Fat percentage remained elevated after 18 months of IGF-I treatment in patients 1 (51%) and 2 (44%), respectively. Lean mass and bone mineral content increased with GH and IGF-I therapies. We conclude that reduction of body fat measured by DEXA, observed after administration of GH but not after IGF-I treatment in these children with GH deficiency, suggests that the GH effect on body fat mass is not mediated by circulating IGF-I. (C)2000, Editrice Kurtis.

Original languageEnglish
Pages (from-to)258-262
Number of pages5
JournalJournal of Endocrinological Investigation
Volume23
Issue number4
StatePublished - Jun 5 2000

Fingerprint

Gene Deletion
Insulin-Like Growth Factor I
Growth Hormone
Adipose Tissue
Therapeutics
Body Composition
Bone and Bones
Photon Absorptiometry
Photons
Bone Density
Fats

Keywords

  • Body composition
  • Body fat
  • GH deficiency
  • GH gene deletions
  • IGF-I treatment

ASJC Scopus subject areas

  • Endocrinology

Cite this

Arnhold, I. J. P., Oliveira, S. B., Osorio, M. G. F., Carrilho, A. J. F., Nicolau, W., Bianco, A. C., & Mendonca, B. B. (2000). Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions. Journal of Endocrinological Investigation, 23(4), 258-262.

Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions. / Arnhold, Ivo J P; Oliveira, S. B.; Osorio, M. G F; Carrilho, A. J F; Nicolau, W.; Bianco, A. C.; Mendonca, B. B.

In: Journal of Endocrinological Investigation, Vol. 23, No. 4, 05.06.2000, p. 258-262.

Research output: Contribution to journalArticle

Arnhold, IJP, Oliveira, SB, Osorio, MGF, Carrilho, AJF, Nicolau, W, Bianco, AC & Mendonca, BB 2000, 'Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions', Journal of Endocrinological Investigation, vol. 23, no. 4, pp. 258-262.
Arnhold, Ivo J P ; Oliveira, S. B. ; Osorio, M. G F ; Carrilho, A. J F ; Nicolau, W. ; Bianco, A. C. ; Mendonca, B. B. / Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions. In: Journal of Endocrinological Investigation. 2000 ; Vol. 23, No. 4. pp. 258-262.
@article{f8b6215693a24c2cb9293a4a486b91dc,
title = "Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions",
abstract = "Two patients with growth hormone (GH) gene deletions were treated with recombinant insulin-like growth factor-I (IGF-I) (80-240 (μg/kg/day) and the effects on bone mass and body composition were compared to administration of GH (0.075 U/kg/day) to 8 patients with idiopathic GH deficiency. Bone mass and body composition were measured by dual photon X-ray absorptiometry (DEXA) before and 3 and 6 months after treatment with GH or IGF-I. Similar increases in growth velocities were observed after GH and IGF-I treatment. Treatment with GH resulted in prompt and significant reduction in body fat percentage (basal, 3 and 6 months: 22±10, 17±9, and 16±9{\%}) whereas body fat percentage remained unchanged after IGF-I therapy (basal, 3 and 6 months: 49, 52 and 48{\%} in patient 1 and 45, 42 and 43{\%} in patient 2, respectively). Fat percentage remained elevated after 18 months of IGF-I treatment in patients 1 (51{\%}) and 2 (44{\%}), respectively. Lean mass and bone mineral content increased with GH and IGF-I therapies. We conclude that reduction of body fat measured by DEXA, observed after administration of GH but not after IGF-I treatment in these children with GH deficiency, suggests that the GH effect on body fat mass is not mediated by circulating IGF-I. (C)2000, Editrice Kurtis.",
keywords = "Body composition, Body fat, GH deficiency, GH gene deletions, IGF-I treatment",
author = "Arnhold, {Ivo J P} and Oliveira, {S. B.} and Osorio, {M. G F} and Carrilho, {A. J F} and W. Nicolau and Bianco, {A. C.} and Mendonca, {B. B.}",
year = "2000",
month = "6",
day = "5",
language = "English",
volume = "23",
pages = "258--262",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "4",

}

TY - JOUR

T1 - Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions

AU - Arnhold, Ivo J P

AU - Oliveira, S. B.

AU - Osorio, M. G F

AU - Carrilho, A. J F

AU - Nicolau, W.

AU - Bianco, A. C.

AU - Mendonca, B. B.

PY - 2000/6/5

Y1 - 2000/6/5

N2 - Two patients with growth hormone (GH) gene deletions were treated with recombinant insulin-like growth factor-I (IGF-I) (80-240 (μg/kg/day) and the effects on bone mass and body composition were compared to administration of GH (0.075 U/kg/day) to 8 patients with idiopathic GH deficiency. Bone mass and body composition were measured by dual photon X-ray absorptiometry (DEXA) before and 3 and 6 months after treatment with GH or IGF-I. Similar increases in growth velocities were observed after GH and IGF-I treatment. Treatment with GH resulted in prompt and significant reduction in body fat percentage (basal, 3 and 6 months: 22±10, 17±9, and 16±9%) whereas body fat percentage remained unchanged after IGF-I therapy (basal, 3 and 6 months: 49, 52 and 48% in patient 1 and 45, 42 and 43% in patient 2, respectively). Fat percentage remained elevated after 18 months of IGF-I treatment in patients 1 (51%) and 2 (44%), respectively. Lean mass and bone mineral content increased with GH and IGF-I therapies. We conclude that reduction of body fat measured by DEXA, observed after administration of GH but not after IGF-I treatment in these children with GH deficiency, suggests that the GH effect on body fat mass is not mediated by circulating IGF-I. (C)2000, Editrice Kurtis.

AB - Two patients with growth hormone (GH) gene deletions were treated with recombinant insulin-like growth factor-I (IGF-I) (80-240 (μg/kg/day) and the effects on bone mass and body composition were compared to administration of GH (0.075 U/kg/day) to 8 patients with idiopathic GH deficiency. Bone mass and body composition were measured by dual photon X-ray absorptiometry (DEXA) before and 3 and 6 months after treatment with GH or IGF-I. Similar increases in growth velocities were observed after GH and IGF-I treatment. Treatment with GH resulted in prompt and significant reduction in body fat percentage (basal, 3 and 6 months: 22±10, 17±9, and 16±9%) whereas body fat percentage remained unchanged after IGF-I therapy (basal, 3 and 6 months: 49, 52 and 48% in patient 1 and 45, 42 and 43% in patient 2, respectively). Fat percentage remained elevated after 18 months of IGF-I treatment in patients 1 (51%) and 2 (44%), respectively. Lean mass and bone mineral content increased with GH and IGF-I therapies. We conclude that reduction of body fat measured by DEXA, observed after administration of GH but not after IGF-I treatment in these children with GH deficiency, suggests that the GH effect on body fat mass is not mediated by circulating IGF-I. (C)2000, Editrice Kurtis.

KW - Body composition

KW - Body fat

KW - GH deficiency

KW - GH gene deletions

KW - IGF-I treatment

UR - http://www.scopus.com/inward/record.url?scp=0034019788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034019788&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 258

EP - 262

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 4

ER -